Preliminary results from an open-label, multicenter phase...

European Journal of Cancer 2020 / 10 Vol. 138

Preliminary results from an open-label, multicenter phase 1/2 dose escalation and expansion study of THOR-707, a novel not-Alpha IL-2, as a single agent in adult subjects with advanced or metastatic solid tumors

Janku, F., Abdul-Karim, R., Azad, A., Bendell, J., Gan, H., Sen, S., Tan, T., Wang, J., Marina, N., Baker, L., Ma, L., Mooney, J., Luo, D., Leveque, J., Milla, M., Meniawy, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
138
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(20)31094-7
Date:
October, 2020
File:
PDF, 34 KB
2020
Conversion to is in progress
Conversion to is failed